Skip to content

Press release -

Journal of Dairy Science publishes third research article on Probios® TC

A paper titled "Direct fed microbial supplementation on ruminal digestion, health, and performance of pre- and postpartum dairy cattle" was published in the Journal of Dairy Science, Vol. 89, No.1, 2006. Authored by Dr. Jim Nocek, partner and owner of Spruce Haven Research Center and technical consultant for Chr. Hansen, the paper is the third refereed Journal of Dairy Science article on Chr. Hansen's Probios® TC.

The paper presents trial data on the effect of feeding transition cows Probios TC, a direct fed microbial (DFM) that contains a specific combination of two Enterococcus strains selected to manage rumen acid load.

Cows supplemented with the DFM had higher ruminal dry matter digestion of both corn silage and haylage than control cows. Supplemented cows consumed more dry matter during both the pre- and postpartum periods, and produced significantly (P < 0.01) more milk than non-supplemented cows.

In other controlled studies on Probios TC, the DFM increased NADIR ruminal pH, mean rumen pH, and mean low daily pH, as well as prepartum and postpartum intake of high-producing dairy cows.

Chr. Hansen designed Probios TC especially for the critical transition period. The organisms in the DFM produce a tonic level of lactic acid, which stabilizes the microflora in the rumen and stimulates dry matter intake. For more information on Probios TC, contact Chr. Hansen at 800-558-0802

Topics


Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark